M&A Deal Summary |
|
---|---|
Date | 2018-05-07 |
Target | Impax Laboratories |
Sector | Life Science |
Buyer(s) | Amneal Pharmaceuticals |
Deal Type | Merger |
Advisor(s) | Morgan Stanley (Financial) Sullivan & Cromwell McDermott Will & Emery (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2002 |
Sector | Healthcare Services |
Employees | 7,850 |
Revenue | 2.4B USD (2023) |
Amneal Pharmaceuticals manufactures and supplies generic pharmaceuticals. The company offers prescription pharmaceutical products in various forms, including oral solids that range from tablets to capsules and soft gels; and liquid-form pharmaceuticals that range from suspensions to solutions. Amneal Pharmaceuticals was incorporated in 2002 and is based in Bridgewater, New Jersey.
DEAL STATS | # |
---|---|
Overall | 3 of 6 |
Sector (Life Science) | 3 of 5 |
Type (Merger) | 1 of 1 |
State (California) | 1 of 1 |
Country (United States) | 3 of 6 |
Year (2018) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2018-05-07 |
Gemini Laboratories
Bridgewater, New Jersey, United States Gemini Laboratories LLC is specialty pharmaceutical company provides a prescription products in various therapeutic areas. Gemini Laboratories was founded in 2013 and is based in Bridgewater, New Jersey. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-05-17 |
Amneal Deutschland
Gröbenzell, Germany Amneal Deutschland GmbH is a manufacturer and distributor of pharmaceuticals products. Amneal Deutschland GmbH is based in Gröbenzell, Germany. |
Sell | - |